Marked Chart Marked Chart Open

The Marked Chart Wire · Business

Obesity Drugs

Eli Lilly and HIMS & Hers partner on obesity drug access

Eli Lilly and Hims & Hers announced a partnership to distribute FDA-approved obesity treatments through Hims' telehealth platform. Foundayo starts at $149 per month, while Zepbound is priced at $299 per month.

LLY+0.4%HIMS+6.6%

Illustration for the Business desk

The stocks in this story

  1. LLY+0.4%Eli Lilly$1,371
  2. HIMS+6.6%Hims & Hers Health$25.64

Prices from Live · updated 9:50 AM ET. Each tile opens the stock's chart and news.

New to this? Read: Reading a stock chart

More Business news

OpenAI

OpenAI reportedly cuts fundraising target to $20 billion

OpenAI is said to have reduced its fundraising goal from $30 billion to $20 billion and lowered its valuation target to $1.25 trillion. Investors including MGX and SoftBank are scaling back commitments ahead of a potential IPO.

Fast headlines, summarized. Not verified and not advice. Check the full story before you act.